FDA Approves Gilead’s Once-Daily Bixlenvo for HIV Treatment, Offering New Options for Patients with Suppressed Virus
The U.S. Food and Drug Administration (FDA) has granted approval for Bixlenvo, a novel once-daily oral pill developed by Gilead Sciences, marking a significant advancement in the management of Human…
